Global $29.84 Billion Implantable Drug Delivery Devices Markets, 2015-2020, 2020-2025F


Dublin, Aug. 12, 2021 (GLOBE NEWSWIRE) -- The "Implantable Drug Delivery Devices Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering.

The global implantable drug delivery devices market is expected to grow from $18.821 billion in 2020 to $20.137 billion in 2021 at a compound annual growth rate (CAGR) of 7%.

The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges.

The market is expected to reach $29.846 billion in 2025 at a CAGR of 10%.

Major players in the implantable drug delivery devices market are Allergan Inc, Bayer HealthCare, Medtronic Inc., Nucletron, Boston Scientific Corporation, Abbott Laboratories, Bausch and Lomb Inc, Merck, Genetech Inc., and Psivida.

The implantable drug delivery devices market consists of sales of implantable drug delivery devices and related services by companies that manufacture them. Implantable drug delivery devices are drug delivery systems implanted by surgery to allow site-specific drug administration at the tissue or organ where the drug is most needed.

Companies and researchers are focusing on developing 3D implantable drug delivery devices. 3D printed titanium transcutaneous ports are implanted behind the patient's ear, allowing healthcare professionals to access the catheters. For instance, in February 2020, Renishaw and Herantis Pharma announced the award-winning device, which received positive results in phase 2 trials, that consists of up to four catheters implanted in the relevant brain areas.

Researchers at King Abdullah University of Science and Technology have introduced a miniaturized drug delivery system suitable for in-vivo biomedical applications. The system consists of an electrolytic pump, which operates a micro bellows membrane as an actuator for delivery through microneedles. A two-photon 3D printing technique was used to make a reservoir equipped with a microneedle.

The implantable drug delivery device market covered in this report is segmented by product into contraceptive implants; spinal implants; brachytherapy seeds; drug-eluting stents; bio-absorbable stents; intraocular stents; infusion pumps; others. It is also segmented by technology into diffusion; osmotic; magnetic; others, and by application into contraception; ophthalmology; cardiovascular; diabetes; oncology; autoimmune diseases; others.

The rising number of product recalls and lawsuits associated with the implantable drug delivery devices is expected to hinder the market. In the past few years, there had been an increase in product recalls and lawsuits connected with these devices. For instance, in December 2019, around 7,000 Medtronic SynchroMed II implantable drug infusion pumps were recalled due to the presence of foreign bodies in them. Nexplanon, a small rod contraceptive implant inserted into the skin of the upper arm to prevent pregnancy for up to three years, is facing a lawsuit, and lawyers and attorneys at National Injury Help have been investigating all such cases against those injured by Nexplanon. Therefore, the rising number of product recalls and lawsuits concerning implantable drug delivery devices is expected to hinder the growth of the market.

The rise in the incidence of target diseases such as diabetic retinopathy, cancer, cardiovascular diseases and other chronic diseases is expected to drive the implantable drug delivery devices market. According to the International Diabetes Federation (IDF), the global prevalence of diabetic retinopathy was around 27% between 2015 and 2019.

Implantable drug delivery devices are used for site-specific drug administration where the drug is most needed, such as Gliadel wafer as an implant used in the treatment of brain tumors, Lupron depot for the treatment of prostate cancer. Hence, due to the site-specific drug administration nature of implantable drug devices, which help in the treatment of target diseases, is driving the implantable drug delivery devices market.

Key Topics Covered:

1. Executive Summary

2. Implantable Drug Delivery Devices Market Characteristics

3. Implantable Drug Delivery Devices Market Trends and Strategies

4. Impact of COVID-19 on Implantable Drug Delivery Devices

5. Implantable Drug Delivery Devices Market Size and Growth
5.1. Global Implantable Drug Delivery Devices Historic Market, 2015-2020, $ Billion
5.1.1. Drivers of the Market
5.1.2. Restraints on The Market
5.2. Global Implantable Drug Delivery Devices Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers of the Market
5.2.2. Restraints on the Market

6. Implantable Drug Delivery Devices Market Segmentation
6.1. Global Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

  • Contraceptive Implants
  • Spinal Implants
  • Brachytherapy Seeds
  • Drug-Eluting Stents
  • Bio-absorbable Stents
  • Intraocular Stents
  • Infusion Pumps
  • Others

6.2. Global Implantable Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

  • Diffusion
  • Osmotic
  • Magnetic
  • Others

6.3. Global Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

  • Contraception
  • Ophthalmology
  • Cardiovascular
  • Diabetes
  • Oncology
  • Autoimmune Diseases
  • Others

7. Implantable Drug Delivery Devices Market Regional and Country Analysis
7.1. Global Implantable Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Implantable Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

Companies Mentioned

  • Allergan Inc
  • Bayer HealthCare
  • Medtronic Inc.
  • Nucletron
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Bausch and Lomb Inc
  • Merck
  • Genetech Inc.
  • Psivida
  • Nucletron

For more information about this report visit https://www.researchandmarkets.com/r/1e4e4k

 

Contact Data